Abeona Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqCM:ABEO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
18 Jun 24	SellUS$116,453	Christine Berni-Silverstein	Individual	25,821	US$4.51
18 Jun 24	SellUS$116,764	Mark Alvino	Individual	25,890	US$4.51
16 May 24	BuyUS$51,799	Leila Alland	Individual	11,000	US$4.71
26 Apr 24	BuyUS$24,764	Faith Charles	Individual	7,550	US$3.28
25 Apr 24	BuyUS$17,609	Joseph Vazzano	Individual	5,608	US$3.14
25 Apr 24	BuyUS$27,864	Brendan O’Malley	Individual	8,600	US$3.24
25 Apr 24	BuyUS$32,000	Vishwas Seshadri	Individual	10,000	US$3.20
06 Feb 24	BuyUS$87,800	Vishwas Seshadri	Individual	20,000	US$4.39
17 Jan 24	SellUS$36,199	Mark Alvino	Individual	7,084	US$5.11

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of ABEO?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	2,225,158	5.12%
General Public	10,058,510	23.1%
Hedge Funds	12,669,762	29.1%
Institutions	18,517,600	42.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 75.5%.

Top Shareholders

Top 25 shareholders own 71.16% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
8.48%	Suvretta Capital Management, LLC	3,685,503	US$21.0m	0%	0.78%
7.9%	Nantahala Capital Management, LLC	3,432,637	US$19.6m	-1.08%	1.49%
7.48%	Adage Capital Management, L.P.	3,249,994	US$18.5m	0%	0.03%
5.29%	Millennium Management LLC	2,301,628	US$13.1m	-14%	0.01%
4.62%	The Vanguard Group, Inc.	2,007,626	US$11.4m	2.77%	no data
4.24%	Vivo Capital, LLC	1,842,751	US$10.5m	0%	0.9%
4.21%	Rosalind Advisors, Inc.	1,832,000	US$10.4m	4.69%	6.42%
3.91%	Western Standard, LLC	1,698,097	US$9.7m	6.99%	9.24%
3.01%	Laurion Capital Management LP	1,306,589	US$7.4m	-13.3%	0.5%
2.99%	Armistice Capital LLC	1,301,114	US$7.4m	0%	0.19%
2.5%	EcoR1 Capital, LLC	1,086,956	US$6.2m	0%	0.21%
2.08%	Vishwas Seshadri	903,887	US$5.2m	-0.03%	no data
1.98%	Walleye Capital LLC	861,301	US$4.9m	-13%	0.04%
1.55%	683 Capital Management, LLC	675,000	US$3.8m	12.5%	0.4%
1.44%	Propel Bio Management, LLC	624,022	US$3.6m	190%	3.42%
1.42%	Citigroup Inc.,Banking and Securities Investments	616,668	US$3.5m	25.8%	no data
1.34%	Ikarian Capital, LLC	583,593	US$3.3m	-24.1%	0.99%
1.1%	BlackRock, Inc.	479,562	US$2.7m	7.42%	no data
1.07%	Geode Capital Management, LLC	465,317	US$2.7m	21.7%	no data
0.94%	Simplify Asset Management Inc.	408,584	US$2.3m	0%	0.16%
0.87%	Newtyn Management, LLC	380,000	US$2.2m	0%	0.25%
0.84%	Joseph Vazzano	365,217	US$2.1m	0%	no data
0.75%	abrdn plc	326,995	US$1.9m	159%	no data
0.63%	Brendan O’Malley	273,289	US$1.6m	0%	no data
0.52%	Bank of America Corporation, Asset Management Arm	226,665	US$1.3m	-1.87%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 12:34
End of Day Share Price	2024/12/20 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Abeona Therapeutics Inc. is covered by 23 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
James Molloy	Alliance Global Partners
George Zavoico	B. Riley Securities, Inc.
Elemer Piros	Cantor Fitzgerald & Co.